JP2017503756A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2017503756A5 JP2017503756A5 JP2016533116A JP2016533116A JP2017503756A5 JP 2017503756 A5 JP2017503756 A5 JP 2017503756A5 JP 2016533116 A JP2016533116 A JP 2016533116A JP 2016533116 A JP2016533116 A JP 2016533116A JP 2017503756 A5 JP2017503756 A5 JP 2017503756A5
- Authority
- JP
- Japan
- Prior art keywords
- muscle activity
- treatment
- deuterium
- abnormal muscle
- structural formula
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201361907675P | 2013-11-22 | 2013-11-22 | |
| US61/907,675 | 2013-11-22 | ||
| PCT/US2014/066740 WO2015077520A1 (en) | 2013-11-22 | 2014-11-21 | Methods of treating abnormal muscular activity |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2017503756A JP2017503756A (ja) | 2017-02-02 |
| JP2017503756A5 true JP2017503756A5 (https=) | 2018-01-11 |
Family
ID=53180159
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016533116A Pending JP2017503756A (ja) | 2013-11-22 | 2014-11-21 | 異常な筋活動を処置する方法 |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US20160303110A1 (https=) |
| EP (1) | EP3071565A4 (https=) |
| JP (1) | JP2017503756A (https=) |
| CA (1) | CA2930167A1 (https=) |
| HK (1) | HK1224294A1 (https=) |
| IL (1) | IL245538A0 (https=) |
| MX (1) | MX2016006622A (https=) |
| WO (1) | WO2015077520A1 (https=) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9550780B2 (en) | 2012-09-18 | 2017-01-24 | Auspex Pharmaceuticals, Inc. | Formulations pharmacokinetics of deuterated benzoquinoline inhibitors of vesicular monoamine transporter 2 |
| CN104684555A (zh) | 2012-09-18 | 2015-06-03 | 奥斯拜客斯制药有限公司 | 囊泡单胺转运体2的氘化苯并喹啉抑制剂的制剂药代动力学 |
| EA201791466A1 (ru) | 2013-12-03 | 2017-11-30 | Оспекс Фармасьютикалз, Инк. | Способы получения соединений бензохинолина |
| EP2918266A1 (en) * | 2014-03-11 | 2015-09-16 | CDRD Berolina AB | Composition comprising a dopamine agonist and an L-DOPA derivative for treating Parkinson's disease |
| HRP20221106T1 (hr) | 2015-03-06 | 2022-11-25 | Auspex Pharmaceuticals, Inc. | Postupci liječenja abnormalnih nevoljnih poremećaja pokreta |
| WO2017180794A1 (en) | 2016-04-13 | 2017-10-19 | Skyline Antiinfectives, Inc. | Deuterated o-sulfated beta-lactam hydroxamic acids and deuterated n-sulfated beta-lactams |
| US10786202B2 (en) | 2016-09-28 | 2020-09-29 | International Business Machines Corporation | Quantifying grip strength and characterizing movement idioms |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7367953B2 (en) * | 2003-11-26 | 2008-05-06 | Ge Medical Systems Global Technology Company | Method and system for determining a period of interest using multiple inputs |
| CA2642593C (en) * | 2006-02-17 | 2014-11-04 | Birds Pharma Gmbh Berolina Innovative Research & Development Services | Deuterated catecholamine derivatives and medicaments comprising said compounds |
| DK2012833T3 (en) * | 2006-05-02 | 2015-01-19 | Univ Pennsylvania | RADIOACTIVALLY LABELED DIHYDROTETRABENAZINE DERIVATIVES AND USE THEREOF AS IMAGING AGENTS |
| US8008500B2 (en) * | 2007-06-08 | 2011-08-30 | General Electric Company | Intermediates useful for making tetrabenazine compounds |
| US9826921B2 (en) * | 2008-06-12 | 2017-11-28 | Global Kinetics Corporation Limited | Detection of hypokinetic and hyperkinetic states |
| PL2318035T3 (pl) * | 2008-07-01 | 2019-10-31 | Curemark Llc | Sposoby i kompozycje do leczenia objawów zaburzeń neurologicznych i zaburzeń zdrowia psychicznego |
| WO2010044981A2 (en) * | 2008-09-18 | 2010-04-22 | Auspex Pharmaceutical ,Inc. | Benzoquinoline inhibitors of vesicular monoamine transporter 2 |
| US20110206782A1 (en) * | 2010-02-24 | 2011-08-25 | Auspex Pharmaceuticals, Inc. | Piperidine modulators of dopamine receptor |
| CA2801061A1 (en) * | 2010-06-01 | 2011-12-08 | Auspex Pharmaceuticals, Inc. | Benzoquinolone inhibitors of vmat2 |
| WO2012006551A2 (en) * | 2010-07-08 | 2012-01-12 | The Brigham And Women's Hospital, Inc. | Neuroprotective molecules and methods of treating neurological disorders and inducing stress granules |
| EP2827856A4 (en) * | 2012-03-23 | 2016-03-09 | Cardero Therapeutics Inc | COMPOUNDS AND COMPOSITIONS FOR THE TREATMENT OF MUSCLE DISEASES |
-
2014
- 2014-11-21 WO PCT/US2014/066740 patent/WO2015077520A1/en not_active Ceased
- 2014-11-21 JP JP2016533116A patent/JP2017503756A/ja active Pending
- 2014-11-21 HK HK16112663.3A patent/HK1224294A1/zh unknown
- 2014-11-21 EP EP14864919.7A patent/EP3071565A4/en not_active Withdrawn
- 2014-11-21 MX MX2016006622A patent/MX2016006622A/es unknown
- 2014-11-21 CA CA2930167A patent/CA2930167A1/en not_active Abandoned
- 2014-11-21 US US15/037,465 patent/US20160303110A1/en not_active Abandoned
-
2016
- 2016-05-08 IL IL245538A patent/IL245538A0/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2017503756A5 (https=) | ||
| EP4663637A3 (en) | Novel deuterium substituted positron emission tomography (pet) imaging agents and their pharmacological application | |
| NZ721645A (en) | Compounds for use as gpr120 agonists | |
| BRPI0821994B8 (pt) | composto ou um enantiômero, um diasteroisômero ou um sal farmaceuticamente aceitável do mesmo, composição farmacêutica, e, uso de um composto | |
| RU2010145459A (ru) | Ингибиторы активности протеинтирозинкиназы | |
| JP2012526791A5 (https=) | ||
| EA201590520A1 (ru) | Фармацевтическая композиция с покрытием, содержащая регорафениб | |
| JOP20180113B1 (ar) | مركبات بيريميدين -2-يل امينو -h1- بيرازول كمثبطات lrrk2 للاستخدام في علاج اضطرابات تنكسية عصبية | |
| FI3738434T3 (fi) | Välituotteita substituoitujen bentsaldehydiyhdisteiden saamiseksi ja menetelmiä niiden käyttöön kudosten hapetuksen lisäämiseksi | |
| HRP20191617T1 (hr) | Kombinacija koja sadrži inhibitor mek i inhibitor b-raf | |
| JP2013032389A5 (https=) | ||
| JP2017506627A5 (https=) | ||
| MY189770A (en) | Biaryl derivative as gpr120 agonists | |
| BR112014005389A8 (pt) | Sal cloridrato de 4- (3-metanossulfonil-fenil) -1- propil-piperidina em uma forma cristalina, composição farmacêutica compreendendo o mesmo e usos do dito sal | |
| JP2013525444A5 (https=) | ||
| MX377202B (es) | Derivado basado en 1,2-naftoquinona y metodo de preparacion del mismo. | |
| RU2008139315A (ru) | Избирательные андрогенные рецепторные модуляторы | |
| MX369956B (es) | Metodos para preparar compuestos de benzoquinolina. | |
| EA201490269A1 (ru) | Новое производное 1,2,3,4-тетрагидрохинолина, подходящее для лечения диабета | |
| JP2014062126A5 (https=) | ||
| BR112022008786A2 (pt) | Composto, composição, uso do composto ou da composição, e, método para tratar ou prevenir uma complicação diabética, doença relacionada à neuroinflamação ou aterosclerose | |
| BR112018006866A2 (pt) | compostos agonistas de ppar, composições farmacêuticas e métodos de uso dos mesmos | |
| BR112017020484A2 (pt) | método para a fabricação de novo composto contendo nitrogênio ou sal do mesmo e intermediário de fabricação do novo composto contendo nitrogênio ou sal do mesmo | |
| EA201591804A1 (ru) | Производные 2-((4-амино-3-(3-фтор-5-гидроксифенил)-1h-пиразоло[3,4-d]пиримидин-1-ил)метил)-3-(2-(трифторметил)бензил)хиназолин-4(3h)-она и их применение в качестве ингибиторов фосфоинозитид-3-киназы | |
| BR112018001534A2 (pt) | inibidor de isocitrato desidrogenase idh1 r132h mutante |